Skip to main content
. Author manuscript; available in PMC: 2010 Apr 19.
Published in final edited form as: Alcohol Clin Exp Res. 2008 Jul;32(7):1113–1123. doi: 10.1111/j.1530-0277.2008.00692.x

Table 4.

Greater Areas of Activity in OPRM1.G Group Compared With the Control Group

Region BA Peak Z-score TLRC
OPRM1.G > Controls
Prepriming
 L ACG 25 2.44 −1, 23, −9
 L OFC* 11 2.41 −26, 35, −13
 L VS/NAc 2.27 −30, 9, −11
 L OFC* 11 2.25 −40, 37, −13
 R IFG 47 2.24 30, 21, −13
 R VS/NAc 2.17 28, 7, −13
 R IFG 47 2.15 28, 19, −13
 R ACG 32 1.99 10, 29, −11
Postpriming
 L IFG 47 2.36 −28, 33, −7
 L globus pallidus 2.13 −18, 1, −5
 L ACG 24 2.10 −12, 27, −3
 R OFC 11 2.08 15, 55, −17
 L ACG 25 2.04 −2, 11, −5
 L OFC 11 2.01 −16, 53, −17
 R claustrum 1.88 30, 11, −7
 R putamen 1.87 18, 15, −7
 R putamen 1.82 20, 17, −7
 R IFG 47 1.81 34, 23, −9
 R medial frontal gyrus 11 1.72 4, 47, −11
Controls > OPRM1.G
Prepriming
 R middle frontal gyrus 10 3.83 30, 51, −1
 R ACG 32 3.03 16, 39, 1
 R globus pallidus 2.47 18, −5, 5
 R caudate 2.46 22, 19, 7
 L thalamus 2.04 −18, −9, 9
 R IFG 47 1.94 16, 15, −23
 L middle frontal gyrus 10 1.86 −22, 51, −1
 R IFG 11 1.80 26, 31, −25
 L VTA/midbrain 1.65 −15, −16, −13
Postpriming
 R IFG 47 3.00 18, 13, −23
 L IFG 47 2.22 −16, 15, −23
 L IFG 11 2.13 −24, 29, −25
 R medial frontal gyrus 9 1.89 6, 51, 23
 L medial frontal gyrus 10 1.83 −18, 49, −3
 L medial frontal gyrus 10 1.70 −12, 47, 1
 L medial frontal gyrus 10 1.70 −6, 55, 15
 R IFG 47 1.67 26, 25, −23

L, left; R, right; ACG, anterior cingulate gyrus; OFC, orbitofrontal cortex; VS/NAc, ventral striatum/nucleus accumbens; IFG, inferior frontal gyrus; VTA, ventral tegmental area.

The OPRM1.G subjects had greater BOLD response in all of the ROIs (except the VTA) before and after priming compared with the controls. Maximum loci of activation are listed for each substrate as anatomical labels, corresponding Brodmann area (BA), peak z-score and Talairach (TLRC) co-ordinates of greater BOLD response in the risk allele group compared with the nonrisk allele group (p < 0.05).

*

Foci of activation (i.e., L OFC) that overlap with DRD4.L individuals.